» Articles » PMID: 32882816

Targeted Metabolomics Analysis on Obstructive Sleep Apnea Patients After Multilevel Sleep Surgery

Abstract

Background: Obstructive sleep apnea (OSA) is caused by partial or complete obstruction of the upper airways. Corrective surgeries aim at removing obstructions in the nasopharynx, oropharynx, and hypopharynx. OSA is associated with an increased risk of various metabolic diseases. Our objective was to evaluate the effect of surgery on the plasma metabolome.

Methods: This study included 39 OSA patients who underwent Multilevel Sleep Surgery (MLS). Clinical and anthropometric measures were taken at baseline and five months after surgery.

Results: The mean Apnea-Hypopnea Index (AHI) significantly dropped from 22.0 ± 18.5 events/hour to 8.97 ± 9.57 events/hour (-Value < 0.001). Epworth's sleepiness Score (ESS) dropped from 12.8 ± 6.23 to 2.95 ± 2.40 (-Value < 0.001), indicating the success of the surgery in treating OSA. Plasma levels of metabolites, phosphocholines (PC) PC.41.5, PC.42.3, ceremide (Cer) Cer.44.0, and triglyceride (TG) TG.53.6, TG.55.6 and TG.56.8 were decreased (-Value < 0.05), whereas lysophosphatidylcholines (LPC) 20.0 and PC.39.3 were increased (-Value < 0.05) after surgery.

Conclusion: This study highlights the success of MLS in treating OSA. Treatment of OSA resulted in an improvement of the metabolic status that was characterized by decreased TG, PCs, and Cer metabolites after surgery, indicating that the success of the surgery positively impacted the metabolic status of these patients.

Citing Articles

Does glial lipid dysregulation alter sleep in Alzheimer's and Parkinson's disease?.

Goodman L, Moulton M, Lin G, Bellen H Trends Mol Med. 2024; 30(10):913-923.

PMID: 38755043 PMC: 11466711. DOI: 10.1016/j.molmed.2024.04.010.


Targeted Metabolomics Analysis of Individuals Carrying the ANGPTL8 R59W Variant.

Abu-Farha M, Joseph S, Mohammad A, Channanath A, Taher I, Al-Mulla F Metabolites. 2023; 13(9).

PMID: 37755252 PMC: 10536441. DOI: 10.3390/metabo13090972.


Hyperfructosemia in sleep disordered breathing: metabolome analysis of Nagahama study.

Nakatsuka Y, Murase K, Sonomura K, Tabara Y, Nagasaki T, Hamada S Sci Rep. 2023; 13(1):12735.

PMID: 37543666 PMC: 10404271. DOI: 10.1038/s41598-023-40002-1.


An integrated multi-omics analysis of sleep-disordered breathing traits implicates P2XR4 purinergic signaling.

Kurniansyah N, Wallace D, Zhang Y, Yu B, Cade B, Wang H Commun Biol. 2023; 6(1):125.

PMID: 36721044 PMC: 9889381. DOI: 10.1038/s42003-023-04520-y.


Increased plasma ANGPTL7 levels with increased obstructive sleep apnea severity.

Leentjens M, Alterki A, Abu-Farha M, Bosschieter P, de Raaff C, de Vries C Front Endocrinol (Lausanne). 2022; 13:922425.

PMID: 36017324 PMC: 9396619. DOI: 10.3389/fendo.2022.922425.


References
1.
Abubaker J, Tiss A, Abu-Farha M, Al-Ghimlas F, Al-Khairi I, Baturcam E . DNAJB3/HSP-40 cochaperone is downregulated in obese humans and is restored by physical exercise. PLoS One. 2013; 8(7):e69217. PMC: 3722167. DOI: 10.1371/journal.pone.0069217. View

2.
Zhang H, Wong C, Wei H, Gilkes D, Korangath P, Chaturvedi P . HIF-1-dependent expression of angiopoietin-like 4 and L1CAM mediates vascular metastasis of hypoxic breast cancer cells to the lungs. Oncogene. 2011; 31(14):1757-70. PMC: 3223555. DOI: 10.1038/onc.2011.365. View

3.
Kheirandish-Gozal L, Philby M, Qiao Z, Khalyfa A, Gozal D . Endothelial Dysfunction in Children With Obstructive Sleep Apnea Is Associated With Elevated Lipoprotein-Associated Phospholipase A2 Plasma Activity Levels. J Am Heart Assoc. 2017; 6(2). PMC: 5523777. DOI: 10.1161/JAHA.116.004923. View

4.
Barros D, Garcia-Rio F . Obstructive sleep apnea and dyslipidemia: from animal models to clinical evidence. Sleep. 2018; 42(3). DOI: 10.1093/sleep/zsy236. View

5.
Gruhle K, Muller S, Meister A, Drescher S . Synthesis and aggregation behaviour of single-chain, 1,32-alkyl branched bis(phosphocholines): effect of lateral chain length. Org Biomol Chem. 2018; 16(15):2711-2724. DOI: 10.1039/c8ob00424b. View